Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc.

Overview
Date Founded

2012

Headquarters

128 Spring Street,Building A,Suite 510,Lexington, MA 02421

Type of Company

Private

Employees (Worldwide)

1 - 10

Industries

Other Business & Consulting Services
Biotechnology
Holding Companies

Company Description

Cyteir Therapeutics, Inc. engages in the development of novel therapeutics and deoxyribonucleic acid repair and synthetic lethal therapies. It exploits the synthetic lethality of gain-of-function DNA-damaging genes and DNA repair inhibition, resulting in selective death among cells. The company was founded by Kevin Mills and Timothy Romberger and is headquartered in Lexington, MA.

Executives & Employees

President & Chief Executive Officer

Chief Scientific Officer

Chief Business Officer

Vice President of Clinical Research & Development

Board of Directors

General Partner, BioPharmaceuticals at LSV Capital Management LLC

Executive Chairman at Thrasos Therapeutics, Inc.

Partner at Venrock Associates

Managing Director at Celgene Corp.

Founder at Cyteir Therapeutics, Inc.

Chief Executive Officer at Convert Pharmaceuticals SA

President & Chief Executive Officer at Cyteir Therapeutics, Inc.

Paths to Cyteir Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Cyteir Therapeutics, Inc.
Recent Transactions
Details Hidden

Cyteir Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Cyteir Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Cyteir Therapeutics, Inc. raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onCyteir Therapeutics, Inc. raised money in a private placement transaction

Advisors & Consultants
Legal Advisor

Practice Group Leader, Business & Technology at Choate Hall & Stewart LLP

Investors
Details Hidden

Osage Partners invests in companies located in the US. The firm targets companies operating in the fields of business-to-business software, data, and technology enabled services companies. They provide financing for early stage capital requirements with an initial investment size ranging from $1 - $4 million as part of $2 – $7 million capital raises . They act as a lead or co-lead investor.

Details Hidden

Novo Ventures is an active manager which provides funding for early and later-stage capital requirements, and provides management support. The firm invests in both public and private companies from Northern Europe and the United States. Novo Ventures targets companies operating in the health technology and health services sector, and industries such as biotechnology and medical specialties. It looks to take minority stake positions in its investments, as well as a seat on the board.

Details Hidden

DROIA NV invests in companies operating exclusively in the oncology sectors located across the globe. They provides investments in seed and early venture rounds and also incubates new companies.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cyteir Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cyteir Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Cyteir Therapeutics, Inc..